New

Tyrosine Kinase Inhibitor Market

2021

Tyrosine Kinase Inhibitor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Others ); Application ( Chronic Myeloid Leukaemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Others ), Impact of covid-19 pandemic.

| Report Code: TIPRE00020860 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Tyrosine Kinase Inhibitor Market 2028 By Type Tyrosine Kinase Inhibitors, Application, Impact of covid-19 pandemic. | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Tyrosine kinase inhibitors are considered as specific enzymes that help in preventing the process of cell division and the growth of cancerous cells. These inhibitors are easy to use and are handy while treating cancer patients by blocking the signals that alert the cancer cells to grow. Tyrosine kinase inhibitors drug discovery has evolved dramatically since last few years. Launch of new drugs and effective approaches for the development of potent and selective inhibitors of cancer cell growth will offer several opportunities for the market.

MARKET DYNAMICS

Tyrosine kinase inhibitor market is driving due to factors such as increasing prevalence of cancer and the increased demand for novel therapies for treatment. However, factor such as the high development cost leads to higher market price of the drug post-approval is expected to hamper the market growth.

MARKET SCOPE

The Tyrosine kinase inhibitor market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Tyrosine kinase inhibitor Market with detailed market segmentation by type and application. The Tyrosine kinase inhibitor Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Tyrosine kinase inhibitor market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Tyrosine kinase inhibitor market is segmented on the basis of type and application. Based on type, market is segmented as BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Others. Based on application, market is segmented as Chronic Myeloid Leukaemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Tyrosine kinase inhibitor market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Tyrosine kinase inhibitor market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Tyrosine kinase inhibitor market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Tyrosine kinase inhibitor market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Tyrosine kinase inhibitor market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as Application and End user launches, Application and End user approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Tyrosine kinase inhibitor market are anticipated to have lucrative growth opportunities in the future with the rising demand for Tyrosine kinase inhibitor in the global market. Below mentioned is the list of few companies engaged in the Tyrosine kinase inhibitor Market.

The report also includes the profiles of key players in Tyrosine kinase inhibitor market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   AstraZeneca PLC
  •   Bayer AG
  •   Boehringer Ingelheim International
  •   Bristol-Myers Squibb Company
  •   Eisai Co, Ltd.
  •   F. Hoffmann-La Roche Ltd.
  •   Johnson and Johnson
  •   Novartis International AG
  •   Pfizer Inc.
  •   Incyte Corporation
  •   Glaxo SmithKline
  •   Takeda Pharmaceutical Company Limited
  •   Celera Genomics Group
  •   Onyx Pharmaceuticals
  •   Chugai Pharmaceutical

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Tyrosine Kinase Inhibitor Market - By Type
1.3.2 Tyrosine Kinase Inhibitor Market - By Application
1.3.3 Tyrosine Kinase Inhibitor Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TYROSINE KINASE INHIBITOR MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TYROSINE KINASE INHIBITOR MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. TYROSINE KINASE INHIBITOR MARKET - GLOBAL MARKET ANALYSIS
6.1. TYROSINE KINASE INHIBITOR - GLOBAL MARKET OVERVIEW
6.2. TYROSINE KINASE INHIBITOR - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. TYROSINE KINASE INHIBITOR MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BCR-ABL TYROSINE KINASE INHIBITOR
7.3.1. Overview
7.3.2. BCR-ABL Tyrosine Kinase Inhibitor Market Forecast and Analysis
7.4. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS
7.4.1. Overview
7.4.2. Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors Market Forecast and Analysis
7.5. VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR (VEGFR) TYROSINE KINASE INHIBITORS
7.5.1. Overview
7.5.2. Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. TYROSINE KINASE INHIBITOR MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CHRONIC MYELOID LEUKEMIA (CML)
8.3.1. Overview
8.3.2. Chronic Myeloid Leukemia (CML) Market Forecast and Analysis
8.4. LUNG CANCER
8.4.1. Overview
8.4.2. Lung Cancer Market Forecast and Analysis
8.5. BREAST CANCER
8.5.1. Overview
8.5.2. Breast Cancer Market Forecast and Analysis
8.6. RENAL CELL CANCER
8.6.1. Overview
8.6.2. Renal Cell Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. TYROSINE KINASE INHIBITOR MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Tyrosine Kinase Inhibitor Market Overview
9.1.2 North America Tyrosine Kinase Inhibitor Market Forecasts and Analysis
9.1.3 North America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Type
9.1.4 North America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Application
9.1.5 North America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Countries
9.1.5.1 United States Tyrosine Kinase Inhibitor Market
9.1.5.1.1 United States Tyrosine Kinase Inhibitor Market by Type
9.1.5.1.2 United States Tyrosine Kinase Inhibitor Market by Application
9.1.5.2 Canada Tyrosine Kinase Inhibitor Market
9.1.5.2.1 Canada Tyrosine Kinase Inhibitor Market by Type
9.1.5.2.2 Canada Tyrosine Kinase Inhibitor Market by Application
9.1.5.3 Mexico Tyrosine Kinase Inhibitor Market
9.1.5.3.1 Mexico Tyrosine Kinase Inhibitor Market by Type
9.1.5.3.2 Mexico Tyrosine Kinase Inhibitor Market by Application
9.2. EUROPE
9.2.1 Europe Tyrosine Kinase Inhibitor Market Overview
9.2.2 Europe Tyrosine Kinase Inhibitor Market Forecasts and Analysis
9.2.3 Europe Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Type
9.2.4 Europe Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Application
9.2.5 Europe Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Tyrosine Kinase Inhibitor Market
9.2.5.1.1 Germany Tyrosine Kinase Inhibitor Market by Type
9.2.5.1.2 Germany Tyrosine Kinase Inhibitor Market by Application
9.2.5.2 France Tyrosine Kinase Inhibitor Market
9.2.5.2.1 France Tyrosine Kinase Inhibitor Market by Type
9.2.5.2.2 France Tyrosine Kinase Inhibitor Market by Application
9.2.5.3 Italy Tyrosine Kinase Inhibitor Market
9.2.5.3.1 Italy Tyrosine Kinase Inhibitor Market by Type
9.2.5.3.2 Italy Tyrosine Kinase Inhibitor Market by Application
9.2.5.4 Spain Tyrosine Kinase Inhibitor Market
9.2.5.4.1 Spain Tyrosine Kinase Inhibitor Market by Type
9.2.5.4.2 Spain Tyrosine Kinase Inhibitor Market by Application
9.2.5.5 United Kingdom Tyrosine Kinase Inhibitor Market
9.2.5.5.1 United Kingdom Tyrosine Kinase Inhibitor Market by Type
9.2.5.5.2 United Kingdom Tyrosine Kinase Inhibitor Market by Application
9.2.5.6 Rest of Europe Tyrosine Kinase Inhibitor Market
9.2.5.6.1 Rest of Europe Tyrosine Kinase Inhibitor Market by Type
9.2.5.6.2 Rest of Europe Tyrosine Kinase Inhibitor Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Tyrosine Kinase Inhibitor Market Overview
9.3.2 Asia-Pacific Tyrosine Kinase Inhibitor Market Forecasts and Analysis
9.3.3 Asia-Pacific Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Tyrosine Kinase Inhibitor Market
9.3.5.1.1 Australia Tyrosine Kinase Inhibitor Market by Type
9.3.5.1.2 Australia Tyrosine Kinase Inhibitor Market by Application
9.3.5.2 China Tyrosine Kinase Inhibitor Market
9.3.5.2.1 China Tyrosine Kinase Inhibitor Market by Type
9.3.5.2.2 China Tyrosine Kinase Inhibitor Market by Application
9.3.5.3 India Tyrosine Kinase Inhibitor Market
9.3.5.3.1 India Tyrosine Kinase Inhibitor Market by Type
9.3.5.3.2 India Tyrosine Kinase Inhibitor Market by Application
9.3.5.4 Japan Tyrosine Kinase Inhibitor Market
9.3.5.4.1 Japan Tyrosine Kinase Inhibitor Market by Type
9.3.5.4.2 Japan Tyrosine Kinase Inhibitor Market by Application
9.3.5.5 South Korea Tyrosine Kinase Inhibitor Market
9.3.5.5.1 South Korea Tyrosine Kinase Inhibitor Market by Type
9.3.5.5.2 South Korea Tyrosine Kinase Inhibitor Market by Application
9.3.5.6 Rest of Asia-Pacific Tyrosine Kinase Inhibitor Market
9.3.5.6.1 Rest of Asia-Pacific Tyrosine Kinase Inhibitor Market by Type
9.3.5.6.2 Rest of Asia-Pacific Tyrosine Kinase Inhibitor Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Tyrosine Kinase Inhibitor Market Overview
9.4.2 Middle East and Africa Tyrosine Kinase Inhibitor Market Forecasts and Analysis
9.4.3 Middle East and Africa Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Tyrosine Kinase Inhibitor Market
9.4.5.1.1 South Africa Tyrosine Kinase Inhibitor Market by Type
9.4.5.1.2 South Africa Tyrosine Kinase Inhibitor Market by Application
9.4.5.2 Saudi Arabia Tyrosine Kinase Inhibitor Market
9.4.5.2.1 Saudi Arabia Tyrosine Kinase Inhibitor Market by Type
9.4.5.2.2 Saudi Arabia Tyrosine Kinase Inhibitor Market by Application
9.4.5.3 U.A.E Tyrosine Kinase Inhibitor Market
9.4.5.3.1 U.A.E Tyrosine Kinase Inhibitor Market by Type
9.4.5.3.2 U.A.E Tyrosine Kinase Inhibitor Market by Application
9.4.5.4 Rest of Middle East and Africa Tyrosine Kinase Inhibitor Market
9.4.5.4.1 Rest of Middle East and Africa Tyrosine Kinase Inhibitor Market by Type
9.4.5.4.2 Rest of Middle East and Africa Tyrosine Kinase Inhibitor Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Tyrosine Kinase Inhibitor Market Overview
9.5.2 South and Central America Tyrosine Kinase Inhibitor Market Forecasts and Analysis
9.5.3 South and Central America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Type
9.5.4 South and Central America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Application
9.5.5 South and Central America Tyrosine Kinase Inhibitor Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Tyrosine Kinase Inhibitor Market
9.5.5.1.1 Brazil Tyrosine Kinase Inhibitor Market by Type
9.5.5.1.2 Brazil Tyrosine Kinase Inhibitor Market by Application
9.5.5.2 Argentina Tyrosine Kinase Inhibitor Market
9.5.5.2.1 Argentina Tyrosine Kinase Inhibitor Market by Type
9.5.5.2.2 Argentina Tyrosine Kinase Inhibitor Market by Application
9.5.5.3 Rest of South and Central America Tyrosine Kinase Inhibitor Market
9.5.5.3.1 Rest of South and Central America Tyrosine Kinase Inhibitor Market by Type
9.5.5.3.2 Rest of South and Central America Tyrosine Kinase Inhibitor Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL TYROSINE KINASE INHIBITOR MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. TYROSINE KINASE INHIBITOR MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAYER AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BOEHRINGER INGELHEIM INTERNATIONAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRISTOL-MYERS SQUIBB COMPANY
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EISAI CO, LTD.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JOHNSON AND JOHNSON
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS INTERNATIONAL AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. INCYTE CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. GLAXO SMITHKLINE
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
12.13. CELERA GENOMICS GROUP
12.13.1. Key Facts
12.13.2. Business Description
12.13.3. Products and Services
12.13.4. Financial Overview
12.13.5. SWOT Analysis
12.13.6. Key Developments
12.14. ONYX PHARMACEUTICALS
12.14.1. Key Facts
12.14.2. Business Description
12.14.3. Products and Services
12.14.4. Financial Overview
12.14.5. SWOT Analysis
12.14.6. Key Developments
12.15. CHUGAI PHARMACEUTICAL
12.15.1. Key Facts
12.15.2. Business Description
12.15.3. Products and Services
12.15.4. Financial Overview
12.15.5. SWOT Analysis
12.15.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca PLC
2. Bayer AG
3. Boehringer Ingelheim International
4. Bristol-Myers Squibb Company
5. Eisai Co, Ltd.
6. F. Hoffmann-La Roche Ltd.
7. Johnson and Johnson
8. Novartis International AG
9. Pfizer Inc.
10. Incyte Corporation
11. Glaxo SmithKline
12. Takeda Pharmaceutical Company Limited
13. Celera Genomics Group
14. Onyx Pharmaceuticals
15. Chugai Pharmaceutical
TIPRE00020860
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.